Did higher NAD+ readings mean better health?

What is the short answer about NAD+ pills?

NAD+ is involved in cells' repair work and their use of food for energy ^[16]. Pill trials raised blood readings, while a benefit for ageing remains unproved.

NAD+ isn't a peptide, despite often appearing alongside peptide products in discussions. Its normal work inside cells differs from the hormone actions of those drugs.

NR pills provide an ingredient for the body to convert into NAD+. As amounts increased, blood NAD+ rose 22, 51 and 142 percent during eight weeks of testing ^[17].

Blood readings rose more at higher amounts, establishing that particular change. NMN, a different ingredient for making NAD+, also raised blood readings over 60 days ^[14].

Each tested amount of NMN gave a greater rise than the comparison treatment. Those blood checks for you don't establish whether your brain or muscles gained a useful supply.

Ageing claims partly rest on finding less NAD+ available in older tissue. NAD+ is needed for repairing DNA, the inherited instructions inside cells ^[16].

Other cell work uses NAD+ too, sometimes more actively with advancing age and more inflammation. Inflammation means swelling and irritation; extra supply might help, but useful human repair hasn't been established.

A review from 2025 found little human benefit and few direct checks inside certain tissues ^[13]. Only a small number of human studies consistently linked greater age with lower NAD+.

For your health, the blood rise leaves the brain, muscles and other organs largely unchecked. Those readings cannot establish slower ageing, better repair or more years of life.

Which ingredients were tested, and what do the rules mean?

NAD+ and its related form NADH both take part in cells using food for energy. Cells change between the two forms while doing that work.

This describes normal work in your body, without showing that extra supply helps. For your product, a first question is whether your ingredient matches the tested ingredient.

Some capsules contain NAD+ itself, also offered as treatment given through a vein. Cells take up little unchanged NAD+, leaving those capsules without strong evidence of benefit.

The better pill studies tested NR or NMN, ingredients the body converts into NAD+. NR and NMN differ from unchanged NAD+ used in capsules.

Finding a benefit with one ingredient cannot show a benefit with a different ingredient for you. Likewise, a pill study doesn't show that treatment through a vein gives the same benefit.

These products are sold as supplements, with legal questions affecting some of the ingredients. According to the FDA, earlier drug studies prevent NMN being sold under the supplement rules.

That statement applies a rule about which kind of testing came first, not fewer safety rules. NMN's legal position remains disputed in the evidence described, without settling whether taking NMN helps people.

Pharmacies usually prepare NAD+ shots and vein treatments, without approval as finished medicines. One injection was recalled in the most serious category, called Class I.

The recalled product contained a high level of harmful material left by bacteria. That danger came from the product's contents, without establishing harm from NAD+ itself.

Supplement bottles can differ in contents and purity, without guaranteed checks by an outside lab. A label alone can't confirm that your bottle matches the ingredient given in a trial.

Why does normal cell work not prove an ageing benefit?

Cells need NAD+ for damage repair and for releasing energy from food. Those normal jobs don't establish that increasing the supply improves your health.

In energy use, the cell changes NAD+ into the related form called NADH. The cell then changes NADH back, allowing the same supply to be used again.

Reusing the supply differs from needing an ever larger supply to release energy. More NAD+ therefore doesn't necessarily make your cells work faster or better.

Repair and certain other cell jobs instead use up NAD+ as they proceed ^[16]. Seven related proteins need that supply for work connected with repair and the use of fuel.

Repairing damage to DNA, the inherited instructions inside your cells, draws on the available NAD+. Other cell activity also breaks the substance down, sometimes more with age and inflammation.

These jobs share a supply that may become smaller as a person grows older. That possible shortage gives researchers a question to test, rather than a proved benefit from pills.

Human trials found increased blood NAD+ after giving ingredients the body converts into NAD+ ^[14][17]. The result establishes a blood rise while the people were receiving those ingredients.

Researchers still need to check whether other tissues get a larger, usable supply. The review found little direct human testing of that question within the tissues concerned ^[13].

Your concern about ageing needs evidence that added supply leads to useful repair. Slower ageing hasn't been established by describing NAD+'s normal role or measuring a blood rise.

What changed in the pill and muscle studies?

The clearest muscle finding was an improved response to insulin in certain women. Other trials raised blood NAD+, without establishing the wide health benefits claimed for products.

NR pills, 2019: NR supplies an ingredient that the body turns into NAD+. Healthy overweight adults took 100, 500 or 1000 milligrams daily during eight weeks of supervised testing ^[17].

Blood NAD+ rose by 22, 51 and 142 percent respectively and remained raised. There was no flushing, meaning warm red skin, or clear excess of side effects over placebo pills without NR.

The cholesterol linked with heart disease didn't rise, and other chemical safety checks found no problem. Those checks weren't tests showing better repair or slower ageing in your body.

These people were healthy and were checked only briefly, mainly for blood changes. Your concern about lasting benefit needs more than a higher NAD+ blood reading.

NMN pills, 2023: This different ingredient also supplies material for making NAD+. Middle-aged adults received 300, 600 or 900 milligrams daily over 60 days ^[14].

Chance decided groups; neither researchers nor participants knew who received NMN and who received placebo. At days 30 and 60, each NMN group had higher blood NAD+ readings than the comparison group.

Walking distance and reported well-being improved, with no safety trouble detected during testing. For this trial's results, researchers judged 600 milligrams daily the best tested amount.

An estimate of biological age, based on body tests rather than birthdays, showed no increase. The estimate didn't show younger age either, leaving slower ageing unproved over the 60 days.

Expectations of benefit can influence walking effort and reports of feeling well. Your health question across years is much wider than improvements during a short trial.

Muscle testing, 2021: Women past menopause, whose periods had ended, received 250 milligrams of NMN daily ^[15]. Their blood sugar was raised but below the diabetes range, and testing lasted ten weeks.

Insulin worked better in the women's muscles; this hormone helps bring blood sugar under control. Researchers checked that response while keeping blood sugar and insulin at controlled levels.

The usual blood test of sugar control over recent months didn't improve during the trial. Nor did the balance between fat and muscle, despite the better muscle response.

The findings concern raised blood sugar in women beyond the end of their periods. They can't establish an ageing benefit for a healthy older person outside that group.

Earlier work reviewed, 2021: Research described lower NAD+ with age in yeast, worms, mice and humans ^[16]. The review described a supply shared between cell repair and other cell work.

Much of the strongest evidence about slower ageing still involved animals and simpler living things. Reviewing that evidence cannot establish a benefit for you that human studies haven't measured.

Human studies reviewed, 2025: The authors found little human benefit and limited testing inside certain tissues ^[13]. Even consistent falls in NAD+ with human age had only limited direct evidence.

What remains unknown about NAD+ benefits and harm?

Personal reports don't reliably establish the benefits or problems commonly experienced with NAD+ products. A person may notice a change without knowing its cause or how often others experience it.

Studies checking blood or muscle changes provide stronger evidence for those particular changes. Even those results leave lasting help and harm unsettled for you.

Cells absorb little unchanged NAD+, so claims about capsules containing NAD+ have weak support. NR and NMN have better pill studies, but contain different ingredients that the body converts to NAD+.

Human blood NAD+ rose in trials ^[14][17], without showing that people lived longer or avoided disease. The 2025 review couldn't connect those blood changes with the wider ageing claims ^[13].

Animal studies and other nonhuman work provide much of the strongest slower-ageing evidence ^[16]. The review of human evidence warns against assuming that people get the same benefit ^[13].

Treatment through a vein is widely advertised, with little testing that fairly compares treated and untreated people. NAD+ also leaves the liquid part of the blood quickly after that treatment.

Chest or belly discomfort and nausea, meaning feeling sick, can follow fast vein treatment. Flushing, a sudden warm reddening of the skin, is another reported problem.

The FDA recalled a pharmacy-made NAD+ injection in its most serious category, Class I. Harmful bacterial material prompted the recall, rather than the normal work NAD+ does inside cells.

An unapproved injection can carry this kind of product risk alongside an unanswered benefit claim. A study of the substance cannot confirm that your injection is clean or contains the right amount.

Cancer is a possible concern because growing cells also need NAD+ for their work. The role in cancer is complicated, and the concern isn't a demonstrated human harm.

NMN's legal position remains disputed, while supplement bottles can differ in contents and purity. Without assured outside testing, your bottle may contain a different ingredient from what researchers tested.

Much of the human testing lasted eight weeks or sixty days ^[14][15][17]. Claims about ageing over thirty years go far beyond the follow-up in those reports.

Your health across decades cannot be established by checking people for a few weeks. Neither lasting help nor lasting harm was settled by those brief studies.

Which tests could establish useful repair inside the body?

NR pills raised blood NAD+ by as much as 142 percent in one study ^[17]. That is a measured blood result, leaving a benefit for ageing unsettled.

A claim about your muscles or brain needs useful changes checked in those tissues. Higher blood readings alone cannot establish where added NAD+ went or what repair followed.

Retatrutide trials checked weight and blood sugar, leaving later illness uncounted. For NAD+, the missing answer begins with the changes inside the tissues behind ageing claims.

Most pill trials measured the blood without directly checking those other tissues. Reviewers in 2025 found too little tissue testing to connect blood rises with slower ageing ^[13].

BPC-157 largely lacks human healing trials, while NAD+ pills have clear human blood results. The missing human BPC-157 evidence differs from the missing tissue tests after a blood rise.

The people enrolled matter as well when you consider a claim about healthy older people. The clearest muscle response involved women past menopause who had raised blood sugar ^[15].

Another trial enrolled middle-aged adults ^[14], without following healthy older people across many years. The advertised ageing benefit for that different group remains unproved by either trial.

The comparison of missing health answers explains these tissue questions and the need for longer follow-up. Your medical history and medicines matter when discussing these limits with a doctor.